A functional null mutation of SCN1B in a patient with Dravet syndrome
- PMID: 19710327
- PMCID: PMC2749953
- DOI: 10.1523/JNEUROSCI.2475-09.2009
A functional null mutation of SCN1B in a patient with Dravet syndrome
Abstract
Dravet syndrome (also called severe myoclonic epilepsy of infancy) is one of the most severe forms of childhood epilepsy. Most patients have heterozygous mutations in SCN1A, encoding voltage-gated sodium channel Na(v)1.1 alpha subunits. Sodium channels are modulated by beta1 subunits, encoded by SCN1B, a gene also linked to epilepsy. Here we report the first patient with Dravet syndrome associated with a recessive mutation in SCN1B (p.R125C). Biochemical characterization of p.R125C in a heterologous system demonstrated little to no cell surface expression despite normal total cellular expression. This occurred regardless of coexpression of Na(v)1.1 alpha subunits. Because the patient was homozygous for the mutation, these data suggest a functional SCN1B null phenotype. To understand the consequences of the lack of beta1 cell surface expression in vivo, hippocampal slice recordings were performed in Scn1b(-/-) versus Scn1b(+/+) mice. Scn1b(-/-) CA3 neurons fired evoked action potentials with a significantly higher peak voltage and significantly greater amplitude compared with wild type. However, in contrast to the Scn1a(+/-) model of Dravet syndrome, we found no measurable differences in sodium current density in acutely dissociated CA3 hippocampal neurons. Whereas Scn1b(-/-) mice seize spontaneously, the seizure susceptibility of Scn1b(+/-) mice was similar to wild type, suggesting that, like the parents of this patient, one functional SCN1B allele is sufficient for normal control of electrical excitability. We conclude that SCN1B p.R125C is an autosomal recessive cause of Dravet syndrome through functional gene inactivation.
Figures








Similar articles
-
Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.Neurobiol Dis. 2014 May;65:1-11. doi: 10.1016/j.nbd.2014.01.006. Epub 2014 Jan 14. Neurobiol Dis. 2014. PMID: 24434335 Free PMC article.
-
A homozygous mutation of voltage-gated sodium channel β(I) gene SCN1B in a patient with Dravet syndrome.Epilepsia. 2012 Dec;53(12):e200-3. doi: 10.1111/epi.12040. Epub 2012 Nov 13. Epilepsia. 2012. PMID: 23148524
-
Voltage-gated Na+ channel β1B: a secreted cell adhesion molecule involved in human epilepsy.J Neurosci. 2011 Oct 12;31(41):14577-91. doi: 10.1523/JNEUROSCI.0361-11.2011. J Neurosci. 2011. PMID: 21994374 Free PMC article.
-
Na channel gene mutations in epilepsy--the functional consequences.Epilepsy Res. 2006 Aug;70 Suppl 1:S218-22. doi: 10.1016/j.eplepsyres.2005.11.025. Epub 2006 Jun 27. Epilepsy Res. 2006. PMID: 16806834 Review.
-
Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies.Epilepsy Res. 2006 Aug;70 Suppl 1:S223-30. doi: 10.1016/j.eplepsyres.2006.01.019. Epub 2006 Jun 27. Epilepsy Res. 2006. PMID: 16806826 Review.
Cited by
-
Sodium channel β subunits: emerging targets in channelopathies.Annu Rev Physiol. 2015;77:481-504. doi: 10.1146/annurev-physiol-021014-071846. Annu Rev Physiol. 2015. PMID: 25668026 Free PMC article. Review.
-
RING finger protein 121 facilitates the degradation and membrane localization of voltage-gated sodium channels.Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2859-64. doi: 10.1073/pnas.1414002112. Epub 2015 Feb 17. Proc Natl Acad Sci U S A. 2015. PMID: 25691753 Free PMC article.
-
Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies.Front Pharmacol. 2012 Jul 11;3:124. doi: 10.3389/fphar.2012.00124. eCollection 2012. Front Pharmacol. 2012. PMID: 22798951 Free PMC article.
-
Hidden behavioral fingerprints in epilepsy.Neuron. 2023 May 3;111(9):1440-1452.e5. doi: 10.1016/j.neuron.2023.02.003. Epub 2023 Feb 24. Neuron. 2023. PMID: 36841241 Free PMC article.
-
Do All Roads Lead to Rome? Genes Causing Dravet Syndrome and Dravet Syndrome-Like Phenotypes.Front Neurol. 2022 Mar 11;13:832380. doi: 10.3389/fneur.2022.832380. eCollection 2022. Front Neurol. 2022. PMID: 35359639 Free PMC article.
References
-
- Amaral MD. Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease. J Inherit Metab Dis. 2006;29:477–487. - PubMed
-
- Audenaert D, Claes L, Ceulemans B, Löfgren A, Van Broeckhoven C, De Jonghe P. A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. Neurology. 2003;61:854–856. - PubMed
-
- Avanzini G, Franceschetti S, Mantegazza M. Epileptogenic channelopathies: experimental models of human pathologies. Epilepsia. 2007;48(Suppl 2):51–64. - PubMed
-
- Baulac S, Huberfeld G, Gourfinkel-An I, Mitropoulou G, Beranger A, Prud'homme JF, Baulac M, Brice A, Bruzzone R, LeGuern E. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet. 2001;28:46–48. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous